Kreon (Pancreas Powder)

Pancreatin supplies the three major digestive enzymes—lipase, amylase and protease. After the enteric‑coated capsule releases its contents in the duodenum, these enzymes break down dietary fats, carbohydrates and proteins, facilitating their absorption and reducing the amount of undigested material that reaches the lower intestine.

The appropriate dose of Kreon is individualized. A qualified prescriber determines the number of capsules based on the patient’s clinical response, dietary fat intake and stool fat measurements. Dosage may be adjusted over time to achieve optimal digestive outcomes.

Safety data for Kreon in pregnancy and lactation are limited. The product should only be used if the potential benefit to the mother outweighs any possible risk to the fetus or infant. Physicians should evaluate each case carefully and discuss uncertainties with the patient.

To request Kreon, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide. After submission, the sales team will verify trade or institutional credentials and respond with pricing, availability, shipping details and any necessary import documentation.

Kreon, like other porcine‑derived enzyme preparations (e.g., Creon, Pancreaze), contains lipase, amylase and protease in an enteric‑coated form. Differences lie mainly in enzyme potency per capsule and dosing schedules. Clinicians may choose a product based on individual patient response, capsule size, and cost considerations.

Kreon capsules should be stored at temperatures below 25 °C, in their original container, and protected from moisture and direct sunlight. Do not expose the product to excessive heat or humidity, as this may compromise the enteric coating and enzyme activity.

Kreon is taken orally, whole, with each main meal and snack that contains fat. The capsule should be swallowed with water and not crushed or chewed, ensuring the enteric coating remains intact until it reaches the duodenum where the enzymes are released.

Serious adverse events, although rare, include allergic reactions such as rash, itching, swelling or anaphylaxis, and intestinal obstruction. Patients should seek immediate medical attention if they experience severe abdominal pain, difficulty breathing, or signs of a hypersensitivity reaction.

Kreon is contraindicated in individuals with a known hypersensitivity to porcine pancreatic tissue or any of its excipients. Patients with severe gastrointestinal obstruction or those who have had recent major abdominal surgery should avoid use until evaluated by a healthcare professional.